| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Progesterone | 47 | 2013 | 681 | 3.510 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 18 | 2020 | 31 | 3.290 |
Why?
|
| Lactoferrin | 19 | 2008 | 74 | 2.430 |
Why?
|
| Progesterone | 31 | 2013 | 450 | 1.930 |
Why?
|
| Receptors, Steroid | 23 | 2018 | 175 | 1.870 |
Why?
|
| Receptors, Thyroid Hormone | 12 | 2018 | 46 | 1.670 |
Why?
|
| DNA-Binding Proteins | 25 | 2018 | 1997 | 1.600 |
Why?
|
| Mammary Glands, Animal | 22 | 2018 | 452 | 1.520 |
Why?
|
| Nerve Tissue Proteins | 15 | 2018 | 1132 | 1.470 |
Why?
|
| Leukemia, Myeloid, Acute | 5 | 2020 | 571 | 1.200 |
Why?
|
| Reproduction | 7 | 2003 | 226 | 0.970 |
Why?
|
| Uterus | 15 | 2006 | 547 | 0.890 |
Why?
|
| Transcription Factors | 20 | 2020 | 2494 | 0.780 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2020 | 2064 | 0.750 |
Why?
|
| Dihydroergotamine | 2 | 2020 | 10 | 0.750 |
Why?
|
| Mice, Knockout | 35 | 2018 | 3873 | 0.740 |
Why?
|
| Mammary Glands, Human | 4 | 2007 | 81 | 0.730 |
Why?
|
| Mammary Neoplasms, Experimental | 7 | 2018 | 239 | 0.710 |
Why?
|
| Animals | 102 | 2020 | 34953 | 0.710 |
Why?
|
| Cell Proliferation | 8 | 2020 | 2512 | 0.710 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2020 | 293 | 0.690 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 11 | 2007 | 326 | 0.690 |
Why?
|
| Mice | 62 | 2020 | 18566 | 0.650 |
Why?
|
| Signal Transduction | 15 | 2020 | 4725 | 0.640 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 210 | 0.580 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2018 | 44 | 0.560 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 757 | 0.550 |
Why?
|
| Gene Expression Regulation | 19 | 2016 | 2444 | 0.540 |
Why?
|
| Vasoconstrictor Agents | 1 | 2018 | 140 | 0.540 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2018 | 634 | 0.530 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2018 | 554 | 0.520 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 226 | 0.510 |
Why?
|
| Tamoxifen | 2 | 2018 | 354 | 0.510 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2018 | 774 | 0.510 |
Why?
|
| Transcriptome | 3 | 2018 | 1124 | 0.500 |
Why?
|
| Dopamine | 13 | 2003 | 253 | 0.500 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2016 | 9 | 0.500 |
Why?
|
| Morphogenesis | 3 | 2013 | 203 | 0.500 |
Why?
|
| Transcription, Genetic | 18 | 2018 | 1425 | 0.460 |
Why?
|
| Receptors, Estrogen | 13 | 2018 | 741 | 0.440 |
Why?
|
| Ovary | 9 | 2006 | 371 | 0.410 |
Why?
|
| Breast Neoplasms | 7 | 2018 | 2683 | 0.390 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 14 | 2010 | 33 | 0.380 |
Why?
|
| Mice, Inbred C57BL | 17 | 2015 | 4764 | 0.370 |
Why?
|
| Sexual Behavior, Animal | 6 | 2006 | 63 | 0.360 |
Why?
|
| Ovulation | 4 | 2010 | 107 | 0.360 |
Why?
|
| Estrogens | 11 | 2001 | 435 | 0.360 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2020 | 998 | 0.360 |
Why?
|
| Estradiol | 10 | 2013 | 488 | 0.360 |
Why?
|
| Cell Movement | 4 | 2008 | 891 | 0.340 |
Why?
|
| Epithelium | 9 | 2013 | 354 | 0.340 |
Why?
|
| Mammary Neoplasms, Animal | 4 | 2007 | 137 | 0.330 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2011 | 127 | 0.320 |
Why?
|
| Myeloproliferative Disorders | 1 | 2011 | 91 | 0.310 |
Why?
|
| Gene Dosage | 1 | 2011 | 449 | 0.300 |
Why?
|
| RNA, Messenger | 17 | 2016 | 2679 | 0.300 |
Why?
|
| Protein Isoforms | 7 | 2003 | 422 | 0.300 |
Why?
|
| DNA | 19 | 2003 | 1483 | 0.290 |
Why?
|
| Embryonic and Fetal Development | 2 | 1999 | 129 | 0.290 |
Why?
|
| Respiratory Burst | 1 | 2008 | 9 | 0.290 |
Why?
|
| Base Sequence | 22 | 2012 | 2902 | 0.290 |
Why?
|
| Mice, Inbred BALB C | 8 | 2018 | 1052 | 0.280 |
Why?
|
| Neutrophils | 3 | 2008 | 360 | 0.280 |
Why?
|
| Breast | 4 | 2007 | 216 | 0.270 |
Why?
|
| Mesencephalon | 4 | 2003 | 39 | 0.270 |
Why?
|
| Recombinant Proteins | 10 | 1998 | 1351 | 0.270 |
Why?
|
| Cloning, Molecular | 15 | 1997 | 813 | 0.260 |
Why?
|
| Iron | 6 | 2003 | 300 | 0.260 |
Why?
|
| Leukemia, Myeloid | 1 | 2007 | 81 | 0.260 |
Why?
|
| Progestins | 1 | 2007 | 45 | 0.260 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2001 | 761 | 0.250 |
Why?
|
| Female | 53 | 2018 | 70680 | 0.250 |
Why?
|
| Gene Expression | 9 | 2009 | 1564 | 0.250 |
Why?
|
| Molecular Sequence Data | 20 | 2006 | 3778 | 0.240 |
Why?
|
| Cell Division | 12 | 2009 | 744 | 0.240 |
Why?
|
| Cell Survival | 3 | 2009 | 869 | 0.230 |
Why?
|
| Genitalia, Female | 2 | 2005 | 46 | 0.230 |
Why?
|
| Immunity, Mucosal | 2 | 2002 | 94 | 0.220 |
Why?
|
| Humans | 53 | 2020 | 132105 | 0.220 |
Why?
|
| Apoptosis | 7 | 2018 | 1904 | 0.220 |
Why?
|
| Plasmids | 8 | 2016 | 459 | 0.220 |
Why?
|
| Chickens | 19 | 1993 | 304 | 0.210 |
Why?
|
| Pyramidal Cells | 1 | 2004 | 167 | 0.200 |
Why?
|
| Blotting, Western | 10 | 2014 | 1085 | 0.200 |
Why?
|
| DNA Damage | 4 | 2018 | 513 | 0.200 |
Why?
|
| Protein Binding | 8 | 2016 | 1735 | 0.190 |
Why?
|
| Cells, Cultured | 9 | 2018 | 3061 | 0.190 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2002 | 305 | 0.190 |
Why?
|
| Semicircular Canals | 1 | 2002 | 20 | 0.190 |
Why?
|
| Embryo Implantation | 2 | 2002 | 229 | 0.190 |
Why?
|
| Tumor Cells, Cultured | 5 | 2018 | 1047 | 0.180 |
Why?
|
| Dermatitis | 1 | 2001 | 28 | 0.180 |
Why?
|
| Axons | 1 | 2004 | 394 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 12 | 2009 | 1294 | 0.180 |
Why?
|
| Genes | 7 | 1992 | 312 | 0.180 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2001 | 57 | 0.170 |
Why?
|
| Cell Cycle Proteins | 2 | 2020 | 686 | 0.170 |
Why?
|
| Oncogenes | 2 | 2020 | 175 | 0.170 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2015 | 1019 | 0.160 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2020 | 52 | 0.160 |
Why?
|
| Neurons | 6 | 2003 | 2016 | 0.150 |
Why?
|
| Seizures | 1 | 2004 | 895 | 0.150 |
Why?
|
| Pregnancy | 13 | 2004 | 7551 | 0.150 |
Why?
|
| Hippocampus | 1 | 2004 | 819 | 0.150 |
Why?
|
| Immunity, Innate | 1 | 2002 | 413 | 0.150 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2016 | 544 | 0.150 |
Why?
|
| Cellular Reprogramming | 1 | 2020 | 130 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2018 | 20 | 0.140 |
Why?
|
| Luteinizing Hormone | 3 | 2010 | 136 | 0.140 |
Why?
|
| Amino Acid Sequence | 12 | 1997 | 2674 | 0.140 |
Why?
|
| Intestinal Mucosa | 1 | 2003 | 796 | 0.140 |
Why?
|
| Gastrointestinal Diseases | 1 | 2001 | 355 | 0.140 |
Why?
|
| Membrane Transport Proteins | 2 | 2012 | 182 | 0.140 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 316 | 0.140 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2009 | 238 | 0.130 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2016 | 236 | 0.130 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 210 | 0.130 |
Why?
|
| Inflammation | 3 | 2018 | 1522 | 0.130 |
Why?
|
| Mice, SCID | 1 | 2018 | 604 | 0.130 |
Why?
|
| Lymph Nodes | 2 | 2000 | 388 | 0.130 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1997 | 67 | 0.130 |
Why?
|
| Mice, Nude | 1 | 2018 | 757 | 0.130 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 265 | 0.130 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2016 | 13 | 0.120 |
Why?
|
| Pro-Opiomelanocortin | 1 | 1997 | 76 | 0.120 |
Why?
|
| Binding Sites | 8 | 1997 | 1256 | 0.120 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2016 | 46 | 0.120 |
Why?
|
| Ovariectomy | 6 | 2006 | 171 | 0.120 |
Why?
|
| Amino Acid Motifs | 1 | 2016 | 205 | 0.120 |
Why?
|
| Posture | 5 | 2006 | 144 | 0.110 |
Why?
|
| Dendritic Cells | 1 | 1998 | 448 | 0.110 |
Why?
|
| Disease Susceptibility | 2 | 2008 | 292 | 0.110 |
Why?
|
| Atherosclerosis | 3 | 2013 | 1000 | 0.110 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2015 | 110 | 0.110 |
Why?
|
| Cell Lineage | 1 | 2016 | 359 | 0.110 |
Why?
|
| Chromosome Mapping | 3 | 2016 | 1097 | 0.110 |
Why?
|
| Ligands | 7 | 2006 | 495 | 0.110 |
Why?
|
| Central Nervous System | 1 | 1996 | 283 | 0.100 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 691 | 0.100 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2013 | 26 | 0.100 |
Why?
|
| Cytoplasmic Granules | 1 | 2014 | 50 | 0.100 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 3698 | 0.100 |
Why?
|
| Mast Cells | 1 | 2014 | 67 | 0.100 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 99 | 0.100 |
Why?
|
| Saccharomyces cerevisiae | 3 | 1993 | 417 | 0.100 |
Why?
|
| Immunohistochemistry | 7 | 2006 | 1723 | 0.100 |
Why?
|
| Mice, Inbred ICR | 3 | 1999 | 152 | 0.100 |
Why?
|
| Early Growth Response Protein 1 | 2 | 2011 | 38 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2018 | 799 | 0.100 |
Why?
|
| Stem Cells | 1 | 1998 | 732 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 1046 | 0.100 |
Why?
|
| Aspergillus oryzae | 1 | 1992 | 8 | 0.100 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2012 | 86 | 0.090 |
Why?
|
| Benzamides | 1 | 2012 | 124 | 0.090 |
Why?
|
| Histones | 1 | 2016 | 538 | 0.090 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 3 | 2006 | 98 | 0.090 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 1992 | 55 | 0.090 |
Why?
|
| Phenotype | 4 | 2011 | 4541 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2012 | 240 | 0.090 |
Why?
|
| Thymus Gland | 2 | 2003 | 100 | 0.090 |
Why?
|
| Pyridines | 1 | 2012 | 249 | 0.090 |
Why?
|
| Epithelial Cells | 5 | 2007 | 903 | 0.090 |
Why?
|
| Organ Specificity | 5 | 2006 | 413 | 0.090 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2011 | 15 | 0.090 |
Why?
|
| Cell Compartmentation | 1 | 2011 | 41 | 0.090 |
Why?
|
| Computational Biology | 1 | 2016 | 873 | 0.080 |
Why?
|
| Pregnancy, Animal | 2 | 2001 | 72 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 1992 | 452 | 0.080 |
Why?
|
| Cumulus Cells | 1 | 2010 | 44 | 0.080 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2010 | 31 | 0.080 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 1989 | 14 | 0.080 |
Why?
|
| Paracrine Communication | 1 | 2010 | 70 | 0.080 |
Why?
|
| Transfection | 10 | 2006 | 999 | 0.080 |
Why?
|
| Genes, p53 | 2 | 2007 | 222 | 0.080 |
Why?
|
| Mice, Inbred Strains | 4 | 2003 | 309 | 0.080 |
Why?
|
| Protein Kinases | 1 | 2011 | 331 | 0.080 |
Why?
|
| Ovarian Follicle | 1 | 2010 | 124 | 0.070 |
Why?
|
| Transferrin | 2 | 2003 | 47 | 0.070 |
Why?
|
| In Situ Hybridization | 3 | 2003 | 470 | 0.070 |
Why?
|
| Mice, Mutant Strains | 5 | 2009 | 378 | 0.070 |
Why?
|
| Blotting, Southern | 3 | 1992 | 214 | 0.070 |
Why?
|
| Mifepristone | 2 | 2006 | 99 | 0.070 |
Why?
|
| Macrophages | 1 | 2013 | 693 | 0.070 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2008 | 63 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 1038 | 0.070 |
Why?
|
| Secretory Vesicles | 1 | 2008 | 21 | 0.070 |
Why?
|
| Monocytes | 1 | 2010 | 344 | 0.070 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2002 | 293 | 0.070 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2008 | 108 | 0.070 |
Why?
|
| Chloroquine | 1 | 2007 | 31 | 0.070 |
Why?
|
| Peroxidase | 1 | 2008 | 64 | 0.070 |
Why?
|
| Aspergillus | 3 | 1997 | 26 | 0.070 |
Why?
|
| Hypothalamus | 3 | 2006 | 210 | 0.070 |
Why?
|
| Benzazepines | 2 | 2006 | 48 | 0.070 |
Why?
|
| Cell Differentiation | 3 | 2008 | 1975 | 0.070 |
Why?
|
| Blast Crisis | 1 | 2007 | 17 | 0.070 |
Why?
|
| NADPH Oxidases | 1 | 2008 | 111 | 0.070 |
Why?
|
| Corpus Striatum | 2 | 2005 | 96 | 0.070 |
Why?
|
| Structure-Activity Relationship | 4 | 2005 | 590 | 0.070 |
Why?
|
| Substance-Related Disorders | 1 | 1992 | 491 | 0.070 |
Why?
|
| Rats, Inbred WF | 6 | 2002 | 16 | 0.070 |
Why?
|
| Phagocytosis | 1 | 2008 | 192 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 1996 | 2553 | 0.060 |
Why?
|
| Multigene Family | 4 | 1997 | 305 | 0.060 |
Why?
|
| Leukocytes | 1 | 2008 | 209 | 0.060 |
Why?
|
| Estrous Cycle | 1 | 2006 | 36 | 0.060 |
Why?
|
| Consensus Sequence | 2 | 1997 | 57 | 0.060 |
Why?
|
| Protein Biosynthesis | 3 | 1989 | 584 | 0.060 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2006 | 44 | 0.060 |
Why?
|
| Models, Biological | 5 | 2003 | 1441 | 0.060 |
Why?
|
| Glycosylation | 2 | 1997 | 126 | 0.060 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2008 | 175 | 0.060 |
Why?
|
| Rats | 8 | 2009 | 3612 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2014 | 1292 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 4 | 1992 | 261 | 0.060 |
Why?
|
| Disease Progression | 2 | 2011 | 2227 | 0.060 |
Why?
|
| NF-kappa B | 2 | 2014 | 454 | 0.060 |
Why?
|
| Mucins | 1 | 2006 | 72 | 0.060 |
Why?
|
| Cell Line | 9 | 1998 | 2730 | 0.060 |
Why?
|
| Alleles | 1 | 2011 | 1684 | 0.060 |
Why?
|
| Dopamine Agonists | 1 | 2006 | 55 | 0.060 |
Why?
|
| Tissue Distribution | 3 | 2006 | 383 | 0.060 |
Why?
|
| Synovial Membrane | 2 | 2002 | 26 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2006 | 190 | 0.060 |
Why?
|
| DNA Primers | 4 | 2012 | 637 | 0.060 |
Why?
|
| Neurotransmitter Agents | 2 | 2003 | 143 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2007 | 679 | 0.060 |
Why?
|
| Wound Healing | 1 | 2009 | 480 | 0.060 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2004 | 19 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2007 | 493 | 0.060 |
Why?
|
| Transcriptional Activation | 4 | 2006 | 430 | 0.060 |
Why?
|
| Kainic Acid | 1 | 2004 | 24 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2002 | 666 | 0.060 |
Why?
|
| Blotting, Northern | 5 | 2001 | 253 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1996 | 128 | 0.050 |
Why?
|
| Membrane Glycoproteins | 2 | 2003 | 421 | 0.050 |
Why?
|
| Staphylococcus aureus | 1 | 2008 | 479 | 0.050 |
Why?
|
| Heat-Shock Proteins | 3 | 1991 | 183 | 0.050 |
Why?
|
| Introns | 2 | 1997 | 304 | 0.050 |
Why?
|
| Acute Disease | 1 | 2007 | 1161 | 0.050 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2003 | 16 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2006 | 403 | 0.050 |
Why?
|
| Cyclins | 2 | 2009 | 100 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2015 | 795 | 0.050 |
Why?
|
| RANK Ligand | 1 | 2003 | 54 | 0.050 |
Why?
|
| Animals, Suckling | 1 | 2003 | 51 | 0.050 |
Why?
|
| Flow Cytometry | 3 | 2013 | 806 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 2 | 1997 | 827 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 1829 | 0.050 |
Why?
|
| Neuropeptides | 1 | 2003 | 117 | 0.050 |
Why?
|
| Animals, Newborn | 2 | 2003 | 1034 | 0.050 |
Why?
|
| Mutation | 5 | 2015 | 6249 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2005 | 470 | 0.050 |
Why?
|
| Exons | 2 | 1997 | 802 | 0.050 |
Why?
|
| Milk | 1 | 2003 | 109 | 0.050 |
Why?
|
| Cytokines | 2 | 2014 | 1367 | 0.050 |
Why?
|
| Duodenum | 1 | 2003 | 113 | 0.050 |
Why?
|
| Adenoviridae | 3 | 2002 | 596 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 329 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2005 | 1050 | 0.050 |
Why?
|
| Host-Parasite Interactions | 1 | 2002 | 82 | 0.040 |
Why?
|
| Carotid Artery Injuries | 1 | 2001 | 37 | 0.040 |
Why?
|
| Methylnitrosourea | 4 | 2002 | 15 | 0.040 |
Why?
|
| Colforsin | 2 | 2001 | 51 | 0.040 |
Why?
|
| Safety | 1 | 2001 | 216 | 0.040 |
Why?
|
| Male | 14 | 2015 | 64918 | 0.040 |
Why?
|
| Postural Balance | 1 | 2002 | 131 | 0.040 |
Why?
|
| Ligases | 1 | 2000 | 40 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 2000 | 162 | 0.040 |
Why?
|
| Langerhans Cells | 1 | 2000 | 21 | 0.040 |
Why?
|
| Gene Targeting | 2 | 1998 | 174 | 0.040 |
Why?
|
| Lung | 1 | 2008 | 1556 | 0.040 |
Why?
|
| Epidermis | 1 | 2000 | 64 | 0.040 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 1999 | 9 | 0.040 |
Why?
|
| Fertility | 2 | 1999 | 260 | 0.040 |
Why?
|
| Models, Animal | 1 | 2002 | 470 | 0.040 |
Why?
|
| Hypersensitivity | 1 | 2002 | 195 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 3 | 1989 | 311 | 0.040 |
Why?
|
| Adenylyl Cyclases | 2 | 1997 | 67 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1999 | 101 | 0.040 |
Why?
|
| Blastocyst | 1 | 1999 | 79 | 0.040 |
Why?
|
| Biotechnology | 2 | 1997 | 59 | 0.040 |
Why?
|
| Intestines | 1 | 2003 | 606 | 0.040 |
Why?
|
| Respiratory System | 1 | 1999 | 98 | 0.040 |
Why?
|
| Homeostasis | 1 | 2003 | 723 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1996 | 309 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 764 | 0.040 |
Why?
|
| Response Elements | 2 | 2010 | 98 | 0.040 |
Why?
|
| Anovulation | 1 | 1997 | 3 | 0.030 |
Why?
|
| Uterine Diseases | 1 | 1997 | 22 | 0.030 |
Why?
|
| Activating Transcription Factor 1 | 1 | 1997 | 4 | 0.030 |
Why?
|
| Embryonic Development | 1 | 1999 | 221 | 0.030 |
Why?
|
| Receptors, Dopamine D1 | 1 | 1997 | 33 | 0.030 |
Why?
|
| Exocrine Glands | 1 | 1997 | 7 | 0.030 |
Why?
|
| Oviducts | 5 | 1989 | 100 | 0.030 |
Why?
|
| Stromal Cells | 1 | 1998 | 303 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 1999 | 460 | 0.030 |
Why?
|
| Brain Chemistry | 2 | 1997 | 118 | 0.030 |
Why?
|
| Pituitary-Adrenal System | 1 | 1997 | 43 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 1997 | 144 | 0.030 |
Why?
|
| Interleukin-1 | 3 | 2002 | 137 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2015 | 377 | 0.030 |
Why?
|
| Mice, Transgenic | 3 | 2015 | 2453 | 0.030 |
Why?
|
| Pituitary Neoplasms | 1 | 1997 | 83 | 0.030 |
Why?
|
| Phosphorylation | 4 | 2009 | 1613 | 0.030 |
Why?
|
| Epitopes | 2 | 1988 | 436 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 1997 | 365 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 1997 | 618 | 0.030 |
Why?
|
| Phytic Acid | 1 | 1995 | 5 | 0.030 |
Why?
|
| Acid Phosphatase | 1 | 1995 | 14 | 0.030 |
Why?
|
| Glucan 1,4-alpha-Glucosidase | 1 | 1995 | 5 | 0.030 |
Why?
|
| Receptors, Dopamine | 2 | 1993 | 32 | 0.030 |
Why?
|
| Coronary Vessels | 2 | 2010 | 549 | 0.030 |
Why?
|
| Dexamethasone | 1 | 1997 | 274 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 1995 | 94 | 0.030 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2015 | 21 | 0.030 |
Why?
|
| Tripartite Motif Proteins | 1 | 2015 | 20 | 0.030 |
Why?
|
| Ubiquitins | 2 | 1992 | 43 | 0.030 |
Why?
|
| Sulfonamides | 1 | 1997 | 282 | 0.030 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 1996 | 93 | 0.030 |
Why?
|
| Gestational Age | 1 | 1999 | 1227 | 0.030 |
Why?
|
| Infertility, Female | 1 | 1996 | 149 | 0.030 |
Why?
|
| Receptors, IgE | 1 | 2014 | 11 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1995 | 448 | 0.030 |
Why?
|
| Tryptases | 1 | 2014 | 17 | 0.030 |
Why?
|
| Cyclin D1 | 2 | 2009 | 113 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 1997 | 270 | 0.030 |
Why?
|
| Hyperplasia | 3 | 2001 | 196 | 0.030 |
Why?
|
| Chemokines | 1 | 2014 | 130 | 0.030 |
Why?
|
| Conalbumin | 1 | 1992 | 1 | 0.030 |
Why?
|
| Age Factors | 2 | 1999 | 2922 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2014 | 180 | 0.020 |
Why?
|
| Genomic Library | 1 | 1992 | 40 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2015 | 323 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1992 | 180 | 0.020 |
Why?
|
| Estrogen Antagonists | 1 | 1993 | 97 | 0.020 |
Why?
|
| Aspergillus nidulans | 1 | 1992 | 24 | 0.020 |
Why?
|
| alpha-Amylases | 1 | 1992 | 12 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 263 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 446 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 1992 | 43 | 0.020 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 2 | 2002 | 52 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2015 | 404 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2003 | 53 | 0.020 |
Why?
|
| Parity | 2 | 2002 | 85 | 0.020 |
Why?
|
| Escherichia coli | 2 | 1995 | 995 | 0.020 |
Why?
|
| Gene Library | 1 | 1992 | 212 | 0.020 |
Why?
|
| Levodopa | 1 | 1992 | 94 | 0.020 |
Why?
|
| Liver | 1 | 1999 | 1806 | 0.020 |
Why?
|
| Carcinogens | 2 | 2002 | 129 | 0.020 |
Why?
|
| Dinoprostone | 2 | 2002 | 70 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 2 | 2002 | 250 | 0.020 |
Why?
|
| Ovalbumin | 1 | 1991 | 123 | 0.020 |
Why?
|
| Steroids | 1 | 1992 | 173 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 1988 | 1038 | 0.020 |
Why?
|
| RNA Splicing | 1 | 1992 | 243 | 0.020 |
Why?
|
| Cattle | 1 | 1992 | 571 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2010 | 5 | 0.020 |
Why?
|
| Molecular Weight | 4 | 1992 | 309 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2010 | 68 | 0.020 |
Why?
|
| Protein Conformation | 2 | 1989 | 825 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2012 | 348 | 0.020 |
Why?
|
| Brain | 2 | 1999 | 3201 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2010 | 327 | 0.020 |
Why?
|
| Cyclin D2 | 1 | 2009 | 15 | 0.020 |
Why?
|
| E2F Transcription Factors | 1 | 2009 | 28 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1992 | 1554 | 0.020 |
Why?
|
| Swine | 1 | 1992 | 1197 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2010 | 332 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2009 | 57 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2009 | 83 | 0.020 |
Why?
|
| Trans-Activators | 1 | 1992 | 714 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2010 | 611 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2007 | 100 | 0.020 |
Why?
|
| Avidin | 1 | 1987 | 13 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 1994 | 1285 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 492 | 0.020 |
Why?
|
| Serotonin | 2 | 1999 | 212 | 0.020 |
Why?
|
| Disease Models, Animal | 3 | 2003 | 4694 | 0.020 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 3 | 1993 | 63 | 0.020 |
Why?
|
| Helicobacter pylori | 1 | 1996 | 1335 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1987 | 87 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2006 | 37 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2006 | 54 | 0.020 |
Why?
|
| Myometrium | 1 | 2006 | 47 | 0.020 |
Why?
|
| Mucin-1 | 1 | 2006 | 38 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1986 | 190 | 0.020 |
Why?
|
| Norepinephrine | 2 | 1999 | 166 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2005 | 33 | 0.010 |
Why?
|
| Cytochromes c | 1 | 2005 | 53 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2005 | 28 | 0.010 |
Why?
|
| Species Specificity | 1 | 1986 | 544 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2001 | 13017 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2006 | 200 | 0.010 |
Why?
|
| Aorta | 1 | 2009 | 554 | 0.010 |
Why?
|
| Quinpirole | 2 | 1997 | 3 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2006 | 347 | 0.010 |
Why?
|
| Methamphetamine | 1 | 2005 | 50 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 180 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2006 | 309 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2005 | 169 | 0.010 |
Why?
|
| alpha-Synuclein | 1 | 2005 | 134 | 0.010 |
Why?
|
| Homozygote | 2 | 1996 | 549 | 0.010 |
Why?
|
| Vesicular Biogenic Amine Transport Proteins | 1 | 2003 | 1 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 2005 | 259 | 0.010 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 2003 | 17 | 0.010 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2003 | 17 | 0.010 |
Why?
|
| Chimera | 2 | 1995 | 84 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2007 | 816 | 0.010 |
Why?
|
| Injections, Intralesional | 1 | 2002 | 47 | 0.010 |
Why?
|
| Thymidine Kinase | 1 | 2002 | 90 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2002 | 139 | 0.010 |
Why?
|
| Ganciclovir | 1 | 2002 | 101 | 0.010 |
Why?
|
| Reproductive History | 1 | 2001 | 10 | 0.010 |
Why?
|
| Perphenazine | 1 | 2001 | 5 | 0.010 |
Why?
|
| Ergolines | 2 | 1991 | 3 | 0.010 |
Why?
|
| Okadaic Acid | 2 | 1991 | 11 | 0.010 |
Why?
|
| Ethers, Cyclic | 2 | 1991 | 13 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2001 | 57 | 0.010 |
Why?
|
| Hormone Antagonists | 1 | 2001 | 49 | 0.010 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2001 | 99 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2001 | 83 | 0.010 |
Why?
|
| Carotid Artery, Common | 1 | 2001 | 66 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2001 | 425 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2002 | 241 | 0.010 |
Why?
|
| Oxazolone | 1 | 2000 | 1 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 1991 | 148 | 0.010 |
Why?
|
| In Vitro Techniques | 2 | 1991 | 868 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2003 | 573 | 0.010 |
Why?
|
| Precipitin Tests | 2 | 1991 | 143 | 0.010 |
Why?
|
| Choline O-Acetyltransferase | 1 | 1999 | 13 | 0.010 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 1999 | 30 | 0.010 |
Why?
|
| Substantia Nigra | 1 | 1999 | 35 | 0.010 |
Why?
|
| Dopamine Agents | 1 | 1999 | 29 | 0.010 |
Why?
|
| Knee Joint | 1 | 2001 | 172 | 0.010 |
Why?
|
| Transplantation Chimera | 1 | 1999 | 43 | 0.010 |
Why?
|
| Genetic Vectors | 2 | 1997 | 927 | 0.010 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2000 | 148 | 0.010 |
Why?
|
| Receptors, Interleukin-8A | 1 | 1999 | 8 | 0.010 |
Why?
|
| DNA Replication | 1 | 2001 | 353 | 0.010 |
Why?
|
| Cell Count | 1 | 1999 | 234 | 0.010 |
Why?
|
| Receptors, Interleukin | 1 | 1999 | 35 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 1999 | 65 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 1999 | 120 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2001 | 1225 | 0.010 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1999 | 171 | 0.010 |
Why?
|
| Diethylstilbestrol | 2 | 1989 | 45 | 0.010 |
Why?
|
| Organ Size | 1 | 1999 | 447 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 1999 | 209 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2001 | 880 | 0.010 |
Why?
|
| DNA Mutational Analysis | 2 | 1991 | 825 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 1999 | 212 | 0.010 |
Why?
|
| Reference Values | 1 | 1999 | 704 | 0.010 |
Why?
|
| Allergens | 1 | 2000 | 276 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1997 | 99 | 0.010 |
Why?
|
| Prolactin | 1 | 1997 | 113 | 0.010 |
Why?
|
| Muscarinic Agonists | 1 | 1997 | 5 | 0.010 |
Why?
|
| Carbachol | 1 | 1997 | 15 | 0.010 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1997 | 77 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 1997 | 81 | 0.010 |
Why?
|
| Isoquinolines | 1 | 1997 | 40 | 0.010 |
Why?
|
| Receptors, Dopamine D2 | 1 | 1997 | 42 | 0.010 |
Why?
|
| Antigens, CD | 1 | 1999 | 437 | 0.010 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1997 | 193 | 0.010 |
Why?
|
| Skin | 1 | 2000 | 538 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1996 | 161 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1997 | 160 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2002 | 822 | 0.010 |
Why?
|
| Endometritis | 1 | 1996 | 8 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1999 | 543 | 0.010 |
Why?
|
| Neuroimmunomodulation | 1 | 1996 | 14 | 0.010 |
Why?
|
| Copulation | 1 | 1995 | 9 | 0.010 |
Why?
|
| Growth Substances | 1 | 1995 | 109 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1997 | 527 | 0.010 |
Why?
|
| Decidua | 1 | 1995 | 136 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2001 | 1879 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2001 | 1018 | 0.010 |
Why?
|
| Incidence | 1 | 2002 | 3365 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1997 | 589 | 0.010 |
Why?
|
| Feedback | 1 | 1995 | 166 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 1995 | 328 | 0.010 |
Why?
|
| Polyunsaturated Alkamides | 1 | 1993 | 25 | 0.010 |
Why?
|
| Bone and Bones | 1 | 1996 | 301 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 6445 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1994 | 454 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 1992 | 48 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 1672 | 0.010 |
Why?
|
| Pheochromocytoma | 1 | 1992 | 38 | 0.010 |
Why?
|
| Nerve Growth Factors | 1 | 1992 | 73 | 0.010 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 1991 | 6 | 0.010 |
Why?
|
| Coturnix | 1 | 1991 | 4 | 0.010 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1992 | 79 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1991 | 97 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1997 | 550 | 0.010 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1991 | 20 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1993 | 732 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1993 | 365 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 1993 | 443 | 0.010 |
Why?
|
| Epinephrine | 1 | 1991 | 155 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1999 | 1758 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1992 | 473 | 0.010 |
Why?
|
| Solubility | 1 | 1990 | 125 | 0.010 |
Why?
|
| Action Potentials | 1 | 1992 | 495 | 0.000 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1989 | 57 | 0.000 |
Why?
|
| Reticulocytes | 1 | 1989 | 33 | 0.000 |
Why?
|
| Cosmids | 1 | 1987 | 42 | 0.000 |
Why?
|
| RNA Caps | 1 | 1987 | 30 | 0.000 |
Why?
|
| Rabbits | 1 | 1989 | 688 | 0.000 |
Why?
|
| Cell Line, Transformed | 1 | 1987 | 161 | 0.000 |
Why?
|
| Metaphase | 1 | 1987 | 33 | 0.000 |
Why?
|
| Hybrid Cells | 1 | 1987 | 78 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1987 | 72 | 0.000 |
Why?
|
| Cricetulus | 1 | 1987 | 93 | 0.000 |
Why?
|
| Immunoblotting | 1 | 1987 | 304 | 0.000 |
Why?
|
| Oncogene Proteins v-erbA | 1 | 1987 | 2 | 0.000 |
Why?
|
| Retroviridae Proteins | 1 | 1987 | 11 | 0.000 |
Why?
|
| Risk Factors | 1 | 2001 | 10902 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1986 | 76 | 0.000 |
Why?
|
| Trypsin | 1 | 1986 | 89 | 0.000 |
Why?
|
| Cricetinae | 1 | 1987 | 381 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1986 | 799 | 0.000 |
Why?
|